You just read:

Prosonix Confirms the Potential of its Multi-Component Particle™ Technology for Developing Novel Inhaled Dual and Triple Combination Therapies for Respiratory Diseases

News provided by

Prosonix

11 Sep, 2014, 09:00 BST